June 2020
CIPA Journal
Another challenge to the propriety of the Patent Trial and Appeal Board (PTAB) – is the Federal Circuit’s Arthrex decision the beginning or the end of this new debate? Emily Gabranski and Tim McAnulty discuss the ramifications and how they are unravelling.
Read the full article here.
United States Patent and Trademark Office (USPTO), Arthrex v. Smith & Nephew , Patent Trial and Appeal Board (PTAB), United States Court of Appeals for the Federal Circuit (CAFC)
Originally printed in CIPA Journal on June 2020. This article is for informational purposes, is not intended to constitute legal advice, and may be considered advertising under applicable state laws. This article is only the opinion of the authors and is not attributable to Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, or the firm’s clients.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.